Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)

Historical Holders from Q1 2016 to Q3 2025

Symbol
ADVM on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
22.2M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
507K
Holdings value
$2.3M
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TCG Crossover GP II, LLC 8.9% 1.87M TCG Crossover GP II, LLC 31 Mar 2025

Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 507K $2.3M $4.53 1
2025 Q2 507K $1.09M $2.15 1
2025 Q1 507K $2.21M $4.37 1
2024 Q4 507K $2.37M $4.67 1
2024 Q3 507K $3.56M -$13.8M $7.02 1
2024 Q2 2.52M $17.3M -$15.1M $6.86 2
2024 Q1 3.58M $50.7M -$65.4M $14.14 3
2023 Q4 64.1M $48.3M -$1.52M $0.75 59
2023 Q3 65.3M $97.9M -$603K $1.50 59
2023 Q2 65.7M $104M +$5.75M $1.59 58
2023 Q1 62.7M $45M +$4.08M $0.72 55
2022 Q4 57.3M $33.2M -$13M $0.58 57
2022 Q3 58.5M $55.6M -$1.28M $0.95 71
2022 Q2 58M $69.6M -$6.82M $1.20 68
2022 Q1 62.9M $82.4M -$1.37M $1.31 83
2021 Q4 65.6M $115M -$8M $1.76 93
2021 Q3 69.6M $151M -$23.1M $2.17 106
2021 Q2 78.7M $275M -$213M $3.50 112
2021 Q1 95.1M $938M +$7.87M $9.86 131
2020 Q4 94.4M $1.02B -$6.88M $10.84 152
2020 Q3 95.2M $980M +$113M $10.30 158
2020 Q2 80.9M $1.69B +$34.7M $20.88 140
2020 Q1 80M $782M +$236M $9.77 125
2019 Q4 56.1M $646M +$34.2M $11.52 114
2019 Q3 49M $267M -$13.5M $5.45 98
2019 Q2 46.4M $549M +$95M $11.89 93
2019 Q1 39.7M $208M +$8.51M $5.24 83
2018 Q4 38.4M $121M -$70.7M $3.15 83
2018 Q3 34.5M $269M -$3.69M $6.05 101
2018 Q2 36.7M $194M +$10.2M $5.30 99
2018 Q1 34.6M $201M +$91.8M $5.80 95
2017 Q4 19.2M $67.3M +$19.6M $3.50 63
2017 Q3 13.6M $49.5M +$3.3M $3.65 56
2017 Q2 13M $32.5M -$1.44M $2.50 60
2017 Q1 13.5M $36.5M +$2.25M $2.70 72
2016 Q4 15.1M $43.8M -$553K $2.90 80
2016 Q3 15.3M $62.7M -$932K $4.11 75
2016 Q2 15.8M $49.8M +$49.1M $3.16 75
2016 Q1 226K $1.17M +$1.14M $5.17 3